Nivolumab and Ipilimumab in Advanced Melanoma

被引：36
|
作者：
Ryu, Hyewon [1 ]
Lee, Hyo Jin [1 ]
机构：
[1] Chungnam Natl Univ, Coll Med, Daejeon, South Korea
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 377卷 / 25期
关键词：
D O I：
10.1056/NEJMc1714339
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2503 / 2503
页数：1
相关论文
共 50 条
  • [1] Nivolumab and ipilimumab therapy for advanced melanoma
    Burki, Talha Khan
    [J]. LANCET ONCOLOGY, 2013, 14 (08): : E298 - E298
  • [2] Nivolumab plus Ipilimumab in Advanced Melanoma
    Wolchok, Jedd D.
    Kluger, Harriet
    Callahan, Margaret K.
    Postow, Michael A.
    Rizvi, Naiyer A.
    Lesokhin, Alexander M.
    Segal, Neil H.
    Ariyan, Charlotte E.
    Gordon, Ruth-Ann
    Reed, Kathleen
    Burke, Matthew M.
    Caldwell, Anne
    Kronenberg, Stephanie A.
    Agunwamba, Blessing U.
    Zhang, Xiaoling
    Lowy, Israel
    Inzunza, Hector David
    Feely, William
    Horak, Christine E.
    Hong, Quan
    Korman, Alan J.
    Wigginton, Jon M.
    Gupta, Ashok
    Sznol, Mario
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02): : 122 - 133
  • [3] Ipilimumab plus nivolumab for advanced melanoma
    Hassel, Jessica C.
    [J]. LANCET ONCOLOGY, 2016, 17 (11): : 1471 - 1472
  • [4] Nivolumab plus ipilimumab in the treatment of advanced melanoma
    Katy K. Tsai
    Adil I. Daud
    [J]. Journal of Hematology & Oncology, 8
  • [5] Nivolumab plus ipilimumab in the treatment of advanced melanoma
    Tsai, Katy K.
    Daud, Adil I.
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
  • [6] Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanoma
    Tetu, Pauline
    Mangana, Joanna
    Dummer, Reinhard
    Dutriaux, Caroline
    Beneton, Nathalie
    Dalle, Stephane
    Meyer, Nicolas
    Oriano, Bastien
    Michielin, Olivier
    Lebbe, Celeste
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 93 : 147 - 149
  • [7] International experience of ipilimumab and nivolumab in patients with advanced melanoma
    Serra-Bellver, P.
    Versluis, J. M.
    Oberoi, H. K.
    Slattery, T. D.
    Khan, Y.
    Patrinelly, J. R.
    da Silva, I. Pires
    Martinez-Vila, C.
    Cook, N.
    Graham, D. M.
    Zhou, C.
    Gupta, A.
    Fernandez, A. M. Arance
    Johnson, D. B.
    Long, G. V.
    Pickering, L.
    Larkin, J.
    Blank, C. U.
    Lorigan, P.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S747 - S748
  • [8] Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
    Wolchok, J. D.
    Chiarion-Sileni, V.
    Gonzalez, R.
    Rutkowski, P.
    Grob, J. -J.
    Cowey, C. L.
    Lao, C. D.
    Wagstaff, J.
    Schadendorf, D.
    Ferrucci, P. F.
    Smylie, M.
    Dummer, R.
    Hill, A.
    Hogg, D.
    Haanen, J.
    Carlino, M. S.
    Bechter, O.
    Maio, M.
    Marquez-Rodas, I.
    Guidoboni, M.
    McArthur, G.
    Lebbe, C.
    Ascierto, P. A.
    Long, G. V.
    Cebon, J.
    Sosman, J.
    Postow, M. A.
    Callahan, M. K.
    Walker, D.
    Rollin, L.
    Bhore, R.
    Hodi, F. S.
    Larkin, J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14): : 1345 - 1356
  • [9] COST-EFFECTIVENESS OF NIVOLUMAB PLUS IPILIMUMAB IN ADVANCED MELANOMA
    Tibet, B.
    [J]. VALUE IN HEALTH, 2018, 21 : S45 - S45
  • [10] Neoadjuvant Ipilimumab/Nivolumab combination in locally advanced or oligometastatic melanoma
    Ferrucci, Pier Francesco
    Lanfrancone, Luisa
    Mazzarella, Luca
    Nezi, Luigi
    Duso, Bruno Achutti
    Manzo, Teresa
    Lotti, Fiorenza
    Gandini, Sara
    Orsolini, Gianmarco
    Pennacchioli, Elisabetta
    Gnagnarella, Patrizia
    Fierro, Maria Teresa
    Senetta, Rebecca
    Riviello, Concetta
    Caliendo, Virginia
    Quaglino, Pietro
    Mazzarol, Giovanni
    Bonizzi, Giuseppina
    Cocorocchio, Emilia
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (SUPPL 1)
12345